Natpara is indicated as an adjunct to calcium and vitamin D to control hypocalcemia in people with hypoparathyroidism. Preotact was approved by the European Medicines Agency for the treatment of osteoporosis in postmenopausal women at high risk of fractures, but the marketing authorisation has been withdrawn at the manufacturer's request.
Recombinant human parathyroid hormone
Streptozotocin
Parathyroid hormone
Calcipotriol
Parathyroid hormone-related protein
Parathyroidectomy
Calcitriol
Calcium/cholecalciferol